These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16459533)

  • 1. Sirolimus: a new immunosuppressant.
    Mukherjee T; Shah BV
    J Assoc Physicians India; 2005 Oct; 53():885-90. PubMed ID: 16459533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin: something old, something new, sometimes borrowed and now renewed.
    Hartford CM; Ratain MJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):381-8. PubMed ID: 17728765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of rapamycin.
    Ley SV; Tackett MN; Maddess ML; Anderson JC; Brennan PE; Cappi MW; Heer JP; Helgen C; Kori M; Kouklovsky C; Marsden SP; Norman J; Osborn DP; Palomero MA; Pavey JB; Pinel C; Robinson LA; Schnaubelt J; Scott JS; Spilling CD; Watanabe H; Wesson KE; Willis MC
    Chemistry; 2009; 15(12):2874-914. PubMed ID: 19204960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression.
    Chen YW; Smith ML; Sheets M; Ballaron S; Trevillyan JM; Burke SE; Rosenberg T; Henry C; Wagner R; Bauch J; Marsh K; Fey TA; Hsieh G; Gauvin D; Mollison KW; Carter GW; Djuric SW
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):228-35. PubMed ID: 17438408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
    Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schäfer H; Detter C; Reichenspurner H
    Transpl Int; 2006 Apr; 19(4):310-8. PubMed ID: 16573547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs.
    Graziani EI
    Nat Prod Rep; 2009 May; 26(5):602-9. PubMed ID: 19387497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus.
    Boernsen KO; Egge-Jacobsen W; Inverardi B; Strom T; Streit F; Schiebel HM; Benet LZ; Christians U
    J Mass Spectrom; 2007 Jun; 42(6):793-802. PubMed ID: 17511017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of pre-rapamycin, the first macrocyclic intermediate in the biosynthesis of the immunosuppressant rapamycin by S. hygroscopicus.
    Gregory MA; Gaisser S; Lill RE; Hong H; Sheridan RM; Wilkinson B; Petkovic H; Weston AJ; Carletti I; Lee HL; Staunton J; Leadlay PF
    Angew Chem Int Ed Engl; 2004 May; 43(19):2551-3. PubMed ID: 15127450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus: its discovery, biological properties, and mechanism of action.
    Sehgal SN
    Transplant Proc; 2003 May; 35(3 Suppl):7S-14S. PubMed ID: 12742462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus in pediatric solid organ transplantation.
    Dharnidharka VR
    Pediatr Transplant; 2005 Aug; 9(4):427-9. PubMed ID: 16048592
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal vs. long-term cyclosporin therapy in Australia.
    Gordois A; Nobes M; Toohey M; Russ G
    Clin Transplant; 2006; 20(4):526-36. PubMed ID: 16842533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature.
    Vivarelli M; Vetrone G; Zanello M; La Barba G; Cucchetti A; Lauro A; Grazi GL; Pinna AD
    Transpl Int; 2006 Dec; 19(12):1022-5. PubMed ID: 17081233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal rapamycin analogues with reduced immunosuppressive activity.
    Dickman DA; Ding H; Li Q; Nilius AM; Balli DJ; Ballaron SJ; Trevillyan JM; Smith ML; Seif LS; Kim K; Sarthy A; Goldman RC; Plattner JJ; Bennani YL
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1405-8. PubMed ID: 10888319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe psoriasis treated with a new macrolide: everolimus.
    Frigerio E; Colombo MD; Franchi C; Altomare A; Garutti C; Altomare GF
    Br J Dermatol; 2007 Feb; 156(2):372-4. PubMed ID: 17223881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Kahan BD
    Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.
    Andrés V; Castro C; Campistol JM
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii14-7. PubMed ID: 16815851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.